Larimar Therapeutics (LRMR) Total Current Liabilities (2016 - 2020)
Historic Total Current Liabilities for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $5.2 million.
- Larimar Therapeutics' Total Current Liabilities fell 6830.9% to $5.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $5.2 million, marking a year-over-year decrease of 6830.9%. This contributed to the annual value of $5.9 million for FY2019, which is 5569.67% down from last year.
- Per Larimar Therapeutics' latest filing, its Total Current Liabilities stood at $5.2 million for Q3 2020, which was down 6830.9% from $6.6 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Total Current Liabilities registered a high of $16.3 million during Q3 2019, and its lowest value of $5.2 million during Q3 2020.
- In the last 5 years, Larimar Therapeutics' Total Current Liabilities had a median value of $9.9 million in 2020 and averaged $10.0 million.
- In the last 5 years, Larimar Therapeutics' Total Current Liabilities skyrocketed by 8409.55% in 2019 and then crashed by 6830.9% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Total Current Liabilities stood at $9.9 million in 2016, then decreased by 26.29% to $7.3 million in 2017, then soared by 82.45% to $13.3 million in 2018, then plummeted by 55.7% to $5.9 million in 2019, then dropped by 12.16% to $5.2 million in 2020.
- Its Total Current Liabilities was $5.2 million in Q3 2020, compared to $6.6 million in Q2 2020 and $9.9 million in Q1 2020.